APOLLO HOSPITALS ENTER L Latest Share Price (APOLLOHOSP)
TODAY IN ONE LINE
APOLLOHOSP rose 2.0% on average volume, outperforming Nifty's 0.3% move, supported by recent strong earnings.
With a market cap of ₹1.26 L Cr., it trades at a P/E of 60.35. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
APOLLO HOSPITALS ENTER L flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Strong Price MomentumRobust returns of 23.1% over 1Y
- ●Earnings GrowthEPS (TTM) grew by a solid 35.6% YoY
- ●Consistent GrowthEPS compounded at 33.3% over 3 years
- ●Quarterly OutperformanceLatest quarter Sales up 165.2% and Profit up 58.5%
- ●Healthy Operating MarginsOPM is structurally strong at 23.5%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.18x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 63.8x
- ●FII SellingFII holding decreased by 1.12% QoQ
- ●Rising Receivables vs SalesReceivables grew 17.7% outpacing sales growth of 14.3%
- ●Promoter Pledging DetectedPledge activity recorded on 30-Sep-2025 17:00
Latest APOLLO HOSPITALS ENTER L News
What changed recently?
Recent events, corporate actions, and announcements.
APOLLO HOSPITALS ENTER. L valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for APOLLO HOSPITALS ENTER. L, framed against the sector median so the premium or discount is obvious at a glance.
APOLLO HOSPITALS ENTER. L trades at a P/E of 60.35× and P/B of 13.30×, against the Healthcare sector median P/E of 45.85×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
APOLLO HOSPITALS ENTER. L technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for APOLLO HOSPITALS ENTER. L — derived from the latest tape, not yesterday's close.
APOLLO HOSPITALS ENTER. L last traded at ₹8,944.5 with an intraday range of ₹8,798–₹8,944.5 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹8944.50| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 9286.33 | +341.83 | +3.82% |
| R3 | 9139.83 | +195.33 | +2.18% |
| R2 | 9042.17 | +97.67 | +1.09% |
| R1 | 8993.33 | +48.83 | +0.55% |
| PIVOT | 8895.67 | -48.83 | -0.55% |
| CURRENT | 8944.50 | — | — |
| S1 | 8846.83 | -97.67 | -1.09% |
| S2 | 8749.17 | -195.33 | -2.18% |
| S3 | 8700.33 | -244.17 | -2.73% |
| S4 | 8553.83 | -390.67 | -4.37% |
APOLLOHOSP is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹8799.5–₹8859.5
Trading Above opening range, showing Bullishness
APOLLO HOSPITALS ENTER. L financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for APOLLO HOSPITALS ENTER. L — consolidated or standalone — with margins, YoY growth and key ratios inline.
APOLLO HOSPITALS ENTER. L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1.26 L Cr. and reported EPS of ₹40.39.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 21,794 | 25,229 ▲ 15.8% |
| Sales Growth YoY %Derived | 14.35% | 15.76% |
| Other Income | 200 | 192 ▼ 4.3% |
| Total Income | 21,994 | 25,420 ▲ 15.6% |
| 11,310 | 13,076 ▲ 15.6% | |
| Gross ProfitDerived | 10,484 | 12,153 ▲ 15.9% |
| Gross Margin %Derived | 48.10% | 48.17% |
| 7,462 | 8,384 ▲ 12.3% | |
| EBITDA (Operating Profit)Derived | 3,022 | 3,769 ▲ 24.7% |
| OPM %Derived | 13.87% | 14.94% |
| 1,216 | 1,307 ▲ 7.4% | |
| Profit Before Tax (PBT) | 2,006 | 2,616 ▲ 30.4% |
| 534 | 658 ▲ 23.3% | |
| Effective Tax %Derived | 26.62% | 25.16% |
| Total Profit for Period | 1,505 | 2,003 ▲ 33.1% |
| Less: Non-controlling Interests | 59 | 61 ▲ 3.0% |
| Net Profit (Owner's PAT)Derived | 1,446 | 1,942 ▲ 34.3% |
| Net Profit Margin %Derived | 6.63% | 7.70% |
| PAT Growth YoY %Derived | 60.91% | 34.29% |
| Earnings Per Share (EPS ₹) | 100.56 | 135.04 ▲ 34.3% |
| Diluted Shares Outstanding (Cr) | 14 | 14 ▲ 0.0% |
| Share of Profit from Associates/JVs | 33 | 45 ▲ 36.1% |
| Other Comprehensive Income (Net of Tax) | -6 | 58 ▲ 1027.0% |
| Total Expenses (incl. D&A & Interest) | 19,988 | 22,804 ▲ 14.1% |
| Material Cost % of RevenueDerived | 12.64% | 12.05% |
| Employee Cost % of RevenueDerived | 12.71% | 11.89% |
| Other Cost % of RevenueDerived | 21.53% | 21.34% |
| Interest Coverage (x)Derived | 4.94x | 6.44x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 8,243 | 9,617 ▲ 16.7% | 11,247 ▲ 16.9% | 10,560 ▼ 6.1% | 14,663 ▲ 38.9% | 16,612 ▲ 13.3% | 19,059 ▲ 14.7% | 21,794 ▲ 14.3% | 25,229 ▲ 15.8% | |
| Sales Growth YoY %Derived | — | 16.67% | 16.94% | -6.11% | 38.85% | 13.30% | 14.73% | 14.35% | 15.76% | |
| Other Income | 32 | 31 ▼ 2.2% | 27 ▼ 14.2% | 45 ▲ 66.8% | 78 ▲ 73.7% | 90 ▲ 15.6% | 106 ▲ 17.7% | 200 ▲ 88.4% | 192 ▼ 4.3% | |
| Total Income | 8,276 | 9,649 ▲ 16.6% | 11,274 ▲ 16.8% | 10,605 ▼ 5.9% | 14,741 ▲ 39.0% | 16,703 ▲ 13.3% | 19,166 ▲ 14.7% | 21,994 ▲ 14.8% | 25,420 ▲ 15.6% | |
4,033 | 4,661 ▲ 15.6% | 5,499 ▲ 18.0% | 5,684 ▲ 3.4% | 7,573 ▲ 33.2% | 8,574 ▲ 13.2% | 9,806 ▲ 14.4% | 11,310 ▲ 15.3% | 13,076 ▲ 15.6% | ||
| Gross ProfitDerived | 4,211 | 4,957 ▲ 17.7% | 5,748 ▲ 16.0% | 4,876 ▼ 15.2% | 7,089 ▲ 45.4% | 8,038 ▲ 13.4% | 9,254 ▲ 15.1% | 10,484 ▲ 13.3% | 12,153 ▲ 15.9% | |
| Gross Margin %Derived | 51.08% | 51.54% | 51.11% | 46.17% | 48.35% | 48.39% | 48.55% | 48.10% | 48.17% | |
3,418 | 3,893 ▲ 13.9% | 4,161 ▲ 6.9% | 3,738 ▼ 10.1% | 4,904 ▲ 31.2% | 5,989 ▲ 22.1% | 6,863 ▲ 14.6% | 7,462 ▲ 8.7% | 8,384 ▲ 12.3% | ||
| EBITDA (Operating Profit)Derived | 793 | 1,064 ▲ 34.1% | 1,587 ▲ 49.2% | 1,137 ▼ 28.3% | 2,185 ▲ 92.1% | 2,050 ▼ 6.2% | 2,391 ▲ 16.6% | 3,022 ▲ 26.4% | 3,769 ▲ 24.7% | |
| OPM %Derived | 9.62% | 11.06% | 14.11% | 10.77% | 14.90% | 12.34% | 12.54% | 13.87% | 14.94% | |
654 | 723 ▲ 10.5% | 1,351 ▲ 86.9% | 1,083 ▼ 19.8% | 1,273 ▲ 17.6% | 996 ▼ 21.8% | 1,138 ▲ 14.3% | 1,216 ▲ 6.8% | 1,307 ▲ 7.4% | ||
| Profit Before Tax (PBT) | 171 | 373 ▲ 117.6% | 660 ▲ 77.2% | 221 ▼ 66.6% | 1,578 ▲ 615.0% | 1,144 ▼ 27.5% | 1,363 ▲ 19.1% | 2,006 ▲ 47.2% | 2,616 ▲ 30.4% | |
112 | 173 ▲ 54.9% | 225 ▲ 29.9% | 85 ▼ 62.4% | 477 ▲ 463.2% | 256 ▼ 46.3% | 446 ▲ 73.9% | 534 ▲ 19.9% | 658 ▲ 23.3% | ||
| Effective Tax %Derived | 65.35% | 46.53% | 34.11% | 38.38% | 30.23% | 22.40% | 32.70% | 26.62% | 25.16% | |
| Total Profit for Period | 60 | 200 ▲ 236.1% | 432 ▲ 115.7% | 137 ▼ 68.3% | 1,108 ▲ 710.4% | 845 ▼ 23.8% | 935 ▲ 10.7% | 1,505 ▲ 61.0% | 2,003 ▲ 33.1% | |
| Less: Non-controlling Interests | -58 | -36 ▲ 38.0% | -23 ▲ 35.5% | -14 ▲ 41.2% | 53 ▲ 487.9% | 26 ▼ 51.7% | 36 ▲ 42.7% | 59 ▲ 62.6% | 61 ▲ 3.0% | |
| Net Profit (Owner's PAT)Derived | 117 | 236 ▲ 101.0% | 455 ▲ 92.7% | 150 ▼ 66.9% | 1,056 ▲ 602.0% | 819 ▼ 22.4% | 899 ▲ 9.7% | 1,446 ▲ 60.9% | 1,942 ▲ 34.3% | |
| Net Profit Margin %Derived | 1.42% | 2.45% | 4.05% | 1.42% | 7.20% | 4.93% | 4.71% | 6.63% | 7.70% | |
| PAT Growth YoY %Derived | — | 101.03% | 92.73% | -66.95% | 602.01% | -22.41% | 9.71% | 60.91% | 34.29% | |
| Earnings Per Share (EPS ₹) | 8.44 | 16.97 ▲ 101.1% | 32.70 ▲ 92.7% | 10.46 ▼ 68.0% | 73.42 ▲ 601.9% | 56.97 ▼ 22.4% | 62.50 ▲ 9.7% | 100.56 ▲ 60.9% | 135.04 ▲ 34.3% | |
| Diluted Shares Outstanding (Cr) | 14 | 14 ▲ 0.0% | 14 ▲ 0.0% | 14 ▲ 3.3% | 14 ▲ 0.0% | 14 ▲ 0.0% | 14 ▲ 0.0% | 14 ▲ 0.0% | 14 ▲ 0.0% | |
| Share of Profit from Associates/JVs | 0 | 1 ▲ 326.1% | -3 ▼ 417.3% | 1 ▲ 124.8% | 7 ▲ 854.5% | -43 ▼ 687.1% | 18 ▲ 141.7% | 33 ▲ 83.3% | 45 ▲ 36.1% | |
| Other Comprehensive Income (Net of Tax) | -17 | -29 ▼ 69.3% | -1 ▲ 97.9% | 15 ▲ 2655.0% | -10 ▼ 163.4% | -13 ▼ 36.5% | -10 ▲ 21.6% | -6 ▲ 39.4% | 58 ▲ 1027.0% | |
| Total Expenses (incl. D&A & Interest) | 8,104 | 9,276 ▲ 14.5% | 10,614 ▲ 14.4% | 10,384 ▼ 2.2% | 13,163 ▲ 26.8% | 15,559 ▲ 18.2% | 17,803 ▲ 14.4% | 19,988 ▲ 12.3% | 22,804 ▲ 14.1% | |
| Material Cost % of RevenueDerived | 17.72% | 17.10% | 16.09% | 15.37% | 18.32% | 13.75% | 12.88% | 12.64% | 12.05% | |
| Employee Cost % of RevenueDerived | 17.04% | 16.62% | 16.48% | 15.16% | 12.18% | 12.90% | 13.08% | 12.71% | 11.89% | |
| Other Cost % of RevenueDerived | 24.42% | 23.86% | 20.52% | 20.24% | 21.26% | 23.14% | 22.92% | 21.53% | 21.34% | |
| Interest Coverage (x)Derived | 1.47x | 2.04x | 1.82x | 1.26x | 4.18x | 3.77x | 3.79x | 4.94x | 6.44x |
APOLLO HOSPITALS ENTER L segment analysis : revenue and profit mix.
Disclosed business segments at APOLLO HOSPITALS ENTER L with their share of revenue and profit, switchable between consolidated and standalone reporting.
APOLLO HOSPITALS ENTER L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for APOLLO HOSPITALS ENTER. L.
Our AI distills the core fundamental drivers supporting APOLLO HOSPITALS ENTER. L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
APOLLO HOSPITALS ENTER. L's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Dominant market capitalization of ₹1.26 LCr establishes scale leadership.
Strong ROE 14.98% and ROCE 14.66% signal superior capital efficiency.
Latest quarterly EPS grew 35.90% YoY, demonstrating strong earnings acceleration.
Minimal debt-to-equity 0.0018x reflects a very conservative capital structure.
Operating cash flow ₹2,059 Cr confirms earnings quality and strong liquidity.
Key Risks.
Elevated P/E 63.83x and PEG 1.91x suggest potential overvaluation.
Operating margin compressed to 11.47% (FY2026), indicating cost inflation pressures.
Latest quarterly sales declined 62.29% sequentially, showing revenue volatility.
FII holdings eased from 49.09% to 42.62%, signaling cautious foreign investor sentiment.
'High Risk' stock level despite fundamentals warrants caution on entry.
Flip Conditions.
Valuation risk. a P/E above 78 (~1.7× the sector multiple of 45.9) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 10% would indicate weaker capital compounding.
APOLLO HOSPITALS ENTER. L peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — APOLLO HOSPITALS ENTER. L is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
APOLLO HOSPITALS ENTER. L chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for APOLLO HOSPITALS ENTER. L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
APOLLO HOSPITALS ENTER. L delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for APOLLO HOSPITALS ENTER. L over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in APOLLO HOSPITALS ENTER. L stood at 75.7% of traded volume, against a 20-day average of 60.7%.
APOLLO HOSPITALS ENTER L announcements: results, concalls, ratings, M&A.
Filings APOLLO HOSPITALS ENTER L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
APOLLO HOSPITALS ENTER L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 152 documents below.
General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
Shareholders meeting
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 25, 2026. Further, the…
Analysts/Institutional Investor Meet/Con. Call Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about Link of Recording
Investor decks & rating reports.
Investor Presentation
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
Investor Presentation
APOLLO HOSPITALS ENTER L dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue APOLLO HOSPITALS ENTER L has declared, sequenced by announce and record date.
APOLLO HOSPITALS ENTER L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
APOLLO HOSPITALS ENTER L insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in APOLLO HOSPITALS ENTER L as reported to SEBI — buying and selling signals from the people who know the business best.
APOLLO HOSPITALS ENTER L insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| K VISHWESHWAR REDDY | Insider | 04 Apr 2025 | buy | +1.50 L | ₹100.72 Cr. | ₹6,714.67 |
| PPN POWER GENERATING CO PVT LTD | Insider | 28 Mar 2025 | buy | +1.3 K | ₹87 L | ₹6,556.14 |
| PPN POWER GENERATING CO PVT LTD | Insider | 24 Mar 2025 | buy | +4.5 K | ₹3.01 Cr. | ₹6,688.89 |
| KARTHIK ANAND | Insider | 19 Mar 2025 | buy | +929 | ₹59.6 L | ₹6,415.50 |
| SUNEETA REDDY | Insider | 11 Mar 2025 | buy | +40.0 K | ₹24.54 Cr. | ₹6,135.00 |
About APOLLO HOSPITALS ENTER. L: business, sector, key facts.
What APOLLO HOSPITALS ENTER. L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
APOLLO HOSPITALS ENTER. L operates in the Hospital industry under the Healthcare sector, listed as NSE: APOLLOHOSP, BSE: 508869.
Apollo Hospitals Enterprise Limited is a leading healthcare provider in India with an international presence. The company's core business revolves around delivering a wide spectrum of healthcare services, encompassing primary, secondary, and tertiary care. This includes a vast array of specialties, ranging from cardiology and oncology to neurosciences and robotic surgery, covering virtually all medical disciplines. Their facilities offer services like transplants, emergency care, and a comprehensive range of diagnostic procedures.
Apollo operates through several distinct segments. The primary segment, Healthcare Services, focuses on its network of hospitals and specialized facilities. Retail Health & Diagnostics encompasses the company's extensive network of pharmacies, clinics, diagnostic centers, and other retail healthcare outlets. The Digital Health & Pharmacy Distribution segment leverages technology through platforms like Apollo 24/7, its mobile health application, and www.apollopharmacy.in, its online pharmacy, to expand access and convenience. Finally, the "Others" segment encompasses diverse activities such as project consultancy, health insurance, medical colleges, and research services.
Beyond its core hospital and clinical services, Apollo's business model is diversified. It includes a substantial retail presence with pharmacies, primary care clinics, and specialized centers for areas such as birthing, dialysis, diabetes management, and dentistry. The company also engages in bio-banking of tissues, indicating a commitment to research and advanced medical technologies. Their educational arm, Medvarsity, provides e-learning opportunities, while their consultancy services extend beyond their direct patient care operations.
In summary, Apollo Hospitals' business strategy focuses on integrated healthcare delivery, combining advanced medical technologies with a broad network of facilities and digital platforms. This integrated approach encompasses a full spectrum of care, from primary healthcare to highly specialized treatments, and utilizes technological advancements to extend its reach and improve accessibility to healthcare services for a wide patient base. Their expansion into diverse related areas such as education, research, and retail demonstrates a comprehensive approach to the healthcare market.
Go deeper on APOLLO HOSPITALS ENTER L
- APOLLO HOSPITALS ENTER L resultsQuarter-by-quarter revenue, profit, EPS and margins for APOLLO HOSPITALS ENTER L.
- APOLLO HOSPITALS ENTER L dividendEvery dividend APOLLO HOSPITALS ENTER L has declared, with ex-dates and yield.
- APOLLO HOSPITALS ENTER L shareholdingPromoter, FII and DII holding in APOLLO HOSPITALS ENTER L, quarter by quarter.
- APOLLO HOSPITALS ENTER L financialsAPOLLO HOSPITALS ENTER L profit & loss, balance sheet and cash flow by year.
- APOLLO HOSPITALS ENTER L technical analysisPivots, CPR and live indicator readings for APOLLO HOSPITALS ENTER L.
- APOLLO HOSPITALS ENTER L corporate actionsBonus issues, splits, rights and buybacks declared by APOLLO HOSPITALS ENTER L.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- DR AGARWALS HEALTH CARE L (AGARWALEYE) Share PricePeer
- ARTEMIS MED SERVICE (ARTEMISMED) Share PricePeer
- ASTER DM QUALITY CARE (ASTERDM) Share PricePeer
- FORTIS HEALTHCARE (FORTIS) Share PricePeer
- GPT HEALTHCARE (GPTHEALTH) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Other overvalued NSE stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about APOLLO HOSPITALS ENTER. L (APOLLOHOSP).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of APOLLO HOSPITALS ENTER. L (APOLLOHOSP)?
The current share price of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) is ₹8,944.50. Today, the stock has gained by ₹176.00 (2.01%), trading in a range of ₹8,798.00 to ₹8,944.50. The stock opened at ₹8,800.00 with a trading volume of 3,44,265 shares.
02Is APOLLO HOSPITALS ENTER. L stock a good investment for long-term?
APOLLO HOSPITALS ENTER. L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1.26 L Cr., P/E ratio of 60.35, ROE of 14.98%, and ROCE of 14.66%. The dividend yield stands at 0.23%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of APOLLO HOSPITALS ENTER. L stock?
The 52-week high price of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) is ₹9,050.00, while the 52-week low is ₹6,696.50. Currently trading at ₹8,944.50, the stock is 33.57% above its 52-week low and 1.17% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy APOLLO HOSPITALS ENTER. L stock at the current price?
Whether to buy APOLLO HOSPITALS ENTER. L stock at ₹8,944.50 depends on multiple factors. The stock is currently trading with a P/E ratio of 60.35 and P/B ratio of 13.3. Today's performance shows a gain of 2.01%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of APOLLO HOSPITALS ENTER. L and when is the next dividend?
APOLLO HOSPITALS ENTER. L offers a dividend yield of 0.23%, which means for every ₹100 invested at the current price of ₹8,944.50, you can expect to receive approximately ₹0.23 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of APOLLO HOSPITALS ENTER. L?
APOLLO HOSPITALS ENTER. L's key financial metrics include: P/E Ratio: 60.35, P/B Ratio: 13.3, ROE: 14.98%, ROCE: 14.66%, Dividend Yield: 0.23%, EPS: ₹40.39, Book Value: ₹693.71, and Debt-to-Equity: 0.18. The company's market cap stands at ₹1.26 L Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is APOLLO HOSPITALS ENTER. L stock performing today in the market?
APOLLO HOSPITALS ENTER. L stock opened at ₹8,800.00 and is currently trading at ₹8,944.50, showing a gain of ₹176.00 (2.01%). The intraday high is ₹8,944.50 and low is ₹8,798.00. The trading volume stands at 3,44,265 shares, indicating moderate market participation today.
08What is the P/E ratio of APOLLO HOSPITALS ENTER. L and what does it indicate?
APOLLO HOSPITALS ENTER. L has a Price-to-Earnings (P/E) ratio of 60.35, which means investors are willing to pay 60.35 for every ₹1 of earnings. With an EPS of ₹40.39, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about APOLLO HOSPITALS ENTER. L (APOLLOHOSP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.